Marquette Asset Management, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1395067
MINNEAPOLIS, MN
Position in GILD
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$27,036
-$4,322 QoQ
Shares Held
214
-4.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#2,115
of 2,266 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Marquette Asset Management, LLC holds $545,493 across 9 Drug Manufacturers - General names. GILD ranks #6 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
935 | $237,461 | |
| 2 | LLY |
ELI LILLY & Co
|
80 | $95,954 | |
| 3 | AMGN |
Amgen Inc
|
185 | $66,992 | |
| 4 | MRK |
Merck & Co., Inc.
|
379 | $48,701 | |
| 5 | ABBV |
AbbVie Inc.
|
140 | $35,229 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
214 | $27,036 | |
| 7 | PFE |
Pfizer Inc
|
832 | $20,034 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
132 | $7,605 |
All Filings in GILD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,036 | 214 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $31,358 | 225 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $21,602 | 176 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $15,096 | 136 | Shares | Sole | 2025-10-24 | |
| No filing history on record for this holder in this stock. | ||||||